We’ve walked through the shadows of rare diseases, stories of struggle, survival, and silence.
Now the spotlight shifts to national policy: will it finally break the silence, or leave patients waiting at the edge of hope?
We’ve walked through the shadows of rare diseases, stories of struggle, survival, and silence.
Now the spotlight shifts to national policy: will it finally break the silence, or leave patients waiting at the edge of hope?